Firms fined for lacking state nod

0 Comment(s)Print E-mail Shanghai Daily, September 30, 2015
Adjust font size:

Fosun Pharma Industrial Development Co, a unit of Shanghai Fosun Pharmaceutical Group, agreed in 2014 to acquire a 65 percent stake in Suzhou Erye Pharma. But Fosun Pharma bought 35 percent of the Suzhou firm before the government gave its approval. Fosun Pharma was fined 200,000 yuan.

The firms were not available for comment yesterday.

Zhao Ying, a researcher at the Institute of Industrial Economics at the Chinese Academy of Social Sciences in Beijing, said: "Over the past three decades, China has established an effective framework of commercial laws in most key business areas and the critical issue is their implementation and enforcement.

"With the country having a complex industry system and a diversified market, China also wants to further tighten its regulatory control on both giant and foreign businesses in the country through administrative actions."

China Daily contributed to this story.

Follow China.org.cn on Twitter and Facebook to join the conversation.
   Previous   1   2  


Print E-mail Bookmark and Share

Go to Forum >>0 Comment(s)

No comments.

Add your comments...

  • User Name Required
  • Your Comment
  • Enter the words you see:   
    Racist, abusive and off-topic comments may be removed by the moderator.
Send your storiesGet more from China.org.cnMobileRSSNewsletter